Abiopharma

Johnson & Johnson - Johnson & Johnson presents newIMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Das auf Tuya-Technologie basierende Unternehmen Conow feiert auf der Intersolar Europe 2026 mit seinem KI-nativen Portfolio für Heimenergie sein großes Debüt in Europa

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Law Offices of Howard G. Smith Encourages First Solar, Inc. (FSLR) Shareholders To Inquire About Securities Fraud Class Action

PCS Edventures! Announces Results for Fiscal Year 2026

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatars Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Conow, un système optimisé par Tuya, fait une entrée remarquée sur la scène européenne lors du salon Intersolar Europe 2026 avec sa gamme de solutions énergétiques domestiques natives de lIA

Deadline Alert: Embecta Corp. (EMBC) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Canacol Energy Secures Key Restructuring Decision from Alberta Court; Colombian Consumer Protections Preserved